We are live on ! Find out more
TECH icon

Bio-Techne

250 hedge funds and large institutions have $3.36B invested in Bio-Techne in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 91 increasing their positions, 93 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

3% more funds holding

Funds holding: 243250 (+7)

2% less repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 93

8% less capital invested

Capital invested by funds: $3.64B → $3.36B (-$275M)

48% less call options, than puts

Call options by funds: $305K | Put options by funds: $592K

Holders
250
Holders Change
+7
Holders Change %
+2.88%
% of All Funds
6.96%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
27
Increased
91
Reduced
93
Closed
19
Calls
$305K
Puts
$592K
Net Calls
-$287K
Net Calls Change
+$156K

TECH Hedge Fund Activity: Q3 2015 in Review

250 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2015, worth a combined $3.36B — down 7.6% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TECH positions and 19 closed out — a net gain of 8 holders — while 91 added to existing stakes and 93 trimmed.

The largest buyer was Atlanta Capital Management, adding an estimated $80.2M. The largest seller was William Blair & Company, cutting an estimated $123M.

  • 250 institutional investors held Bio-Techne (TECH) as of Q3 2015, up from 243 in Q2 2015.
  • Funds reported $3.36B of Bio-Techne stock for Q3 2015, down 7.6% quarter-over-quarter.
  • 27 funds opened new Bio-Techne positions in Q3 2015 and 19 closed out, a net change of +8 holders.
  • The largest Bio-Techne buyer in Q3 2015 was Atlanta Capital Management, an estimated $80.2M added.
  • The largest Bio-Techne seller in Q3 2015 was William Blair & Company, an estimated $123M sold.

Based on aggregated 13F filings for Q3 2015.